Treace Medical Concepts (TMCI) Free Cash Flow (2020 - 2026)

Treace Medical Concepts has reported Free Cash Flow for 7 years, with the latest figure at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 537.86% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at -$26.0 million (up 29.75% YoY), and the FY2025 full-year result was -$29.5 million, up 39.53% from the prior year.
• Free Cash Flow for Q1 2026 stood at $4.2 million, up from -$10.4 million in the prior quarter.
• The five-year high for Free Cash Flow was $4.2 million in Q1 2026, with the low at -$18.7 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$9.7 million across 5 years, with a median of -$11.1 million in 2024.
• Annual changes were most pronounced in 2022 — Free Cash Flow sank 1258.57% — and 2026, when it soared 537.86%.
• Treace Medical Concepts' Free Cash Flow stood at -$7.7 million in 2022, then surged by 77.69% to -$1.7 million in 2023, then plunged by 324.3% to -$7.3 million in 2024, then sank by 43.17% to -$10.4 million in 2025, then soared by 140.08% to $4.2 million in 2026.
• The last three Free Cash Flow figures came in at $4.2 million (Q1 2026), -$10.4 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.